1. McAuslane N, Cone M, Collins J. A cross regional comparison of the regulatory environment in emerging markets. CMR International Institute for Regulatory Science R&D Briefing No. 50, February 2006. Available at: http://www.cmr.org/institute/PDF/RD50.PDF/institute/PDF/RD50.PDF.
2. Walker S, Cone M, Collins J. The emerging markets: regulatory issues and the impact on patients’ access to medicines. CMR International Institute for Regulatory Science Workshop Report. April 2006. Available from Institute@cmr.org.
3. Walker S, McAuslane N, Cone M, Collins J. Emerging markets: models of best practice for the regulatory review of new medicines. CMR International Institute for Regulatory Science Workshop Report, March 2008. Available from lnstitute@cmr.org.
4. Cone M, McAuslane N. Building quality into regulatory activities: what does it mean? CMR International Institute for Regulatory Science R&D Briefing No. 46, June 2006. Available at: http://www.cmr.org/institute/PDF/RD46.PDF/institute/PDF/RD46.PDF.